Provided by Tiger Trade Technology Pte. Ltd.

Warrior Met Coal LLC

108.24
+1.171.09%
Volume:612.79K
Turnover:66.51M
Market Cap:5.69B
PE:26.02
High:110.50
Open:109.05
Low:107.91
Close:107.07
52wk High:111.20
52wk Low:54.66
Shares:52.57M
Float Shares:51.78M
Volume Ratio:1.07
T/O Rate:1.18%
Dividend:0.32
Dividend Rate:0.30%
EPS(TTM):4.16
EPS(LYR):1.08
ROE:10.04%
ROA:5.17%
PB:2.48
PE(LYR):100.22

Loading ...

China Producer Price Pressure Puts Silvercorp Metals And Mining Stocks In Focus

Simply Wall St.
·
Jul 10

HCC Healthcare Signs Business Combination Agreement with RF Acquisition Corp III to Pursue Nasdaq Listing

GlobeNewswire
·
Jul 10

Warrior Met Coal (HCC) Gets a Buy from Jefferies

TIPRANKS
·
Jul 09

RBC Capital Sticks to Their Hold Rating for Warrior Met Coal (HCC)

TIPRANKS
·
Jul 09

Can-Fite Achieves Key Pivotal Phase 3 Psoriasis Milestone with Completion of Patient Enrolment for the Interim Analysis: Data Expected Q4 2026/Q1 2027

GlobeNewswire
·
Jul 06

Can-Fite Phase 2a Pancreatic Cancer Study with Namodenoson Achieves Primary Safety Endpoint and Demonstrates Durable Survival Outcomes in Advanced Disease

GlobeNewswire
·
Jul 01

3 US Manufacturing Stocks Tied To Onshoring And Trade Tariff Shifts

Simply Wall St.
·
Jul 01

Warrior Met Coal is Maintained at Buy by UBS

Dow Jones
·
Jul 01

UBS Adjusts Price Target on Warrior Met Coal to $100 From $102, Maintains Buy Rating

MT Newswires Live
·
Jun 30

UBS Keeps Their Buy Rating on Warrior Met Coal (HCC)

TIPRANKS
·
Jun 30

Can-Fite Secures Japanese Patent Allowance for Namodenoson's Anti-Obesity Technology

GlobeNewswire
·
Jun 26

HENLIUS Announces First US Patient Dosed in Global Phase 1 Trial for HLX13, an Ipilimumab Biosimilar, in First-Line Unresectable Advanced Liver Cancer

Stock News
·
Jun 25

SQM Stock And 2 Global Exporters For Investors Looking Beyond Tech

Simply Wall St.
·
Jun 24

Warrior Met Coal’s (HCC) Insider Sales Amid Rich Valuation: What Do They Signal About Risk‑Reward?

Simply Wall St.
·
Jun 24

Can-Fite Publishes Peer-Reviewed Scientific Article Demonstrating the Broad Therapeutic Potential of Piclidenoson and Namodenoson

GlobeNewswire
·
Jun 22

Can-Fite to Present Late-Stage Clinical Pipeline and Licensing Opportunities at BIO International Convention 2026

GlobeNewswire
·
Jun 17

Warrior Met Coal Is Maintained at Buy by B. Riley Securities

Dow Jones
·
Jun 11

Warrior Met Coal Inc : B. Riley Raises Target Price to $123 From $117

THOMSON REUTERS
·
Jun 10

B. Riley Raises Price Target on Warrior Met Coal to $123 From $117, Keeps Buy Rating

MT Newswires Live
·
Jun 10

Warrior Met Coal Chief Administrative Officer Kelli K. Gant sells 20,000 shares for $2.2 million

Reuters
·
Jun 05